ERBB2 and neoplasm: Third, HER2 detection from Cell‐free DNA (cfDNA) or circulating tumor DNA (ctDNA) was possible to be hampered in clinical practice due to the common limitation of cfDNA and ctDNA: low concentration ratio of ctDNA:cfDNA, strict analytical steps, higher input sample volume requirement, and higher costs.23, 24, 25